Exercise therapy for hip impingement syndrome
The Effect of Patients' Characteristics on the Responsiveness to Exercise Therapy for the Management of Femoroacetabular Impingement Syndrome: a Multi-center, Single-group, Intervention Study
This study tests if a 12-week exercise program can help people with hip impingement syndrome feel less pain and improve their hip function.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 50 Years |
| Sex | All |
| Sponsor | Schulthess Klinik Academic / other |
| Locations | 1 site (Zurich) |
| Trial ID | NCT04502043 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates how patients with femoroacetabular impingement syndrome (FAIS) respond to a 12-week exercise therapy program. Participants will be recruited from two clinical centers and will undergo assessments of hip pain, function, and quality of life at multiple follow-up points. Additionally, hip joint contact pressure will be analyzed through motion analysis, and imaging will be used to evaluate hip morphology. The study aims to identify characteristics that differentiate responders from non-responders to the exercise intervention.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 50 with a diagnosis of femoroacetabular impingement syndrome.
Not a fit: Patients who have had previous hip surgery, significant cardiopulmonary diseases, or severe hip osteoarthritis may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a non-surgical management option for patients suffering from FAIS, improving their quality of life and reducing the need for surgical interventions.
How similar studies have performed: Other studies have shown positive outcomes with exercise therapy for similar conditions, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age: 18 to 50 years; * Diagnosis of FAIS; * Availability of magnetic resonance arthrography and anteroposterior pelvic radiography of the involved hip; * Signed informed consent form. Exclusion Criteria: * Previous hip surgery; * Any surgery on the lower extremities in the last 6 months; * Hip dysplasia: lateral center edge angle \<25°; * Hip osteoarthritis: Tönnis grade \>1; * BMI: \>35 kg/m2; * Significant cardiopulmonary diseases.
Where this trial is running
Zurich
- Schulthess Clinic — Zurich, Switzerland (Recruiting)
Study contacts
- Principal investigator: Nicola C Casartelli, PhD — Schulthess Klinik
- Study coordinator: Nicola C Casartelli, PhD
- Email: nicola.casartelli@kws.ch
- Phone: 0443857971
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.